Shannon Jackson
Psychiatric/Mental Health · Seattle, WANPI 1851842843
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 139 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 11.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,999, more than ten times the $84 reported in 2021. Among psychiatric/mental health clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 139 payments — averaging $54.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$867
- AbbVie$644
- Gilead$586
- AstraZeneca$491
- Johnson & Johnson$437
- Neurocrine Biosciences, Inc.$349
- plus $4K from 32 others
What the payments were for
- Food & beverage$7,612100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Austedo XR$485
- VRAYLAR$478
- DEXCOM G7 GSS (161)$285
- SPRAVATO$265
- Epclusa$258
- CAPLYTA$227
- DEXCOM STELO GLUCOSE BIOSENSOR$163
- Dyanavel XR$152
- INTERSTIM$151
- Strensiq$135
- FreeStyle Libre 2$128
- AJOVY$125
- GEMTESA$125
- DUPIXENT$125
- Repatha$125
- MOUNJARO$125
- Auvelity$125
- JARDIANCE$125
- Fanapt$125
- COBENFY$123
How this compares
$7,612 in reported general payments places this provider in the 95th percentile of 931 psychiatric/mental health providers in Washington.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 40 | $51,255 |
| MounjaroTirzepatide | 39 | $42,858 |
| JanuviaSitagliptin Phosphate | 34 | $35,399 |
| TrulicityDulaglutide | 21 | $29,614 |
| EliquisApixaban | 20 | $29,130 |
| OzempicSemaglutide | 17 | $21,611 |
| FarxigaDapagliflozin Propanediol | 16 | $18,424 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 174 | $8,110 |
| MovantikNaloxegol Oxalate | 15 | $7,062 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 66 | $6,220 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $5,819 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 24 | $2,985 |
| Gabapentin | 188 | $2,875 |
| Atorvastatin Calcium | 359 | $2,843 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 14 | $2,413 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $125 | $72,47260 claims |
| Boehringer IngelheimJardiance | $125 | $51,25540 claims |
| MerckJanuvia | $111 | $35,39934 claims |
| AstraZenecaFarxiga, Symbicort | $491 | $24,24328 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 931 psychiatric/mental health providers in Washington.
Other psychiatric/mental health in Seattle
- Kelly BlissSeattle$18K
- Anthony DelosreyesSeattle$9K
- Emma NaumanSeattle$4K
- Angela CombsRichland$121K
- Ashley McGinnisAuburn$26K
- Courtney YantPuyallup$26K
- Dawn MasonSpokane$25K
- Jennifer WilsonYakima$23K
- Kojo SarfoEllensburg$20K
- Brendan RoeVancouver$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.